Literature DB >> 6706376

Anaphylaxis following intranasal challenge of mice sensitized with ovalbumin.

A C McCaskill, C S Hosking, D J Hill.   

Abstract

Mice sensitized with two intraperitoneal injections of ovalbumin and challenged intranasally with the same antigen developed a non-fatal anaphylactic shock peaking in severity 30 min after challenge. Increases in haematocrit were noted which corresponded to the severity of signs of shock displayed by mice. Severity of shock also correlated with IgE and IgG levels. Sensitization by the nasal route, and use of B. pertussis vaccine as adjuvant had no qualitative effect upon the response. Cobra venom factor depletion of C3 in vivo did not alter the response of mice, which suggests anaphylaxis did not involve complement activation. Sensitivity was not transferrable to non-immune mice with serum. Passive sensitization with polyclonal and monoclonal antibodies produced inconsistent results. Possible mechanisms of anaphylaxis are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6706376      PMCID: PMC1454558     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  MECHANISM OF ANAPHYLACTIC DEATH IN THE MOUSE.

Authors:  J MUNOZ; R K BERGMAN
Journal:  Nature       Date:  1965-01-09       Impact factor: 49.962

2.  Histopathological changes in mice treated with extracts of the histamine-sensitizing factor of Bordetella pertussis.

Authors:  S B Lehrer; R M Nakamura; E M Tan
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

3.  Repeatable micro-shocks of constant strength in guinea-pig anaphylaxis.

Authors:  H HERXHEIMER
Journal:  J Physiol       Date:  1952-06       Impact factor: 5.182

4.  Failure of rat and rabbit antiserum to passively sensitize normal and pertussis-treated rats and mice so as to induce mast cell damage and histamine release on later contact with antigen.

Authors:  I MOTA
Journal:  Immunology       Date:  1962-01       Impact factor: 7.397

Review 5.  The allergic phenotype: manifestation of 'allergic breakthrough' and imbalance in normal 'damping' of IgE antibody production.

Authors:  D H Katz
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

6.  A simple method of raising antiserum to the third fraction of mouse serum complement.

Authors:  A K Gupta; K M Rao
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Microdetermination of rabbit immunoglobulin allotypes by ELISA using specific antibodies conjugated with peroxidase or with biotin.

Authors:  S Jackson; J A Sogn; T J Kindt
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

8.  Continuous production of monoclonal mouse IgE antibodies with known allergenic specificity by a hybrid cell line.

Authors:  I Böttcher; G Hämmerling
Journal:  Nature       Date:  1978-10-26       Impact factor: 49.962

9.  Enzyme and radioimmunoassays for specific murine IgE and IgG with different solid-phase immunosorbents.

Authors:  A Giallongo; L Kochoumian; T P King
Journal:  J Immunol Methods       Date:  1982-08-13       Impact factor: 2.303

10.  The respiratory response of sensitized rats to challenge with antigen aerosols.

Authors:  H Piechuta; M E Smith; N N Share; G Holme
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

View more
  1 in total

1.  Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.

Authors:  Maelíosa T C McCrudden; Barbara M Torrisi; Sharifah Al-Zahrani; Cian M McCrudden; Marija Zaric; Christopher J Scott; Adrien Kissenpfennig; Helen O McCarthy; Ryan F Donnelly
Journal:  J Pharm Pharmacol       Date:  2014-03-27       Impact factor: 3.765

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.